Fractionated scheme of oral vinorelbine as single-agent therapy or in combination with cisplatin concomitantly with thoracic radiotherapy in stage III non-small-cell lung cancer: Dose-escalation phase i trial

Clinical Lung Cancer

Volumn 15, Issue 4, 2014, Pages 266-273

  Krzakowski, Maciej ^a   Lucas, Christel ^b   Gridelli, Cesare ^c  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^c S G MOSCATI HOSPITAL   (Italy)

Author keywords

Locally advanced; NSCLC; Radiotherapy; Vinorelbine

Indexed keywords

CISPLATIN; NAVELBINE; ANTINEOPLASTIC AGENT; VINBLASTINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DEHYDRATION; DIARRHEA; DRUG DOSE ESCALATION; ESOPHAGITIS; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEUTROPENIA; OPEN STUDY; PHASE 1 CLINICAL TRIAL; PNEUMONIA; RADIATION DOSE; RECOMMENDED DRUG DOSE; THORACIC RADIOTHERAPY; THROMBOCYTOPENIA; TREATMENT RESPONSE; YOUNG ADULT; ANALOGS AND DERIVATIVES; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; INTERNATIONAL COOPERATION; LUNG NEOPLASMS; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; CLINICAL PROTOCOLS; DOSE FRACTIONATION; ESOPHAGITIS; FEMALE; HUMANS; INTERNATIONAL COOPERATION; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM STAGING; TREATMENT OUTCOME; VINBLASTINE;

EID: 84903191949     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2014.02.002     Document Type: Article

References (25)

1. A.J. Alberg, M.W. Brock, and J.M. Samet Epidemiology of lung cancer: looking to the future J Clin Oncol 23 2005 3175 3185
2. J.P. Pignon, and L.A. Stewart Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIA and IIIb non small cell lung cancer: a meta-analysis Cancer 77 1996 2413 2414
3. A. Aupérin, C. Le Péchoux, and E. Rolland et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
4. L. Crinò, W. Weder, and J. van Meerbeeck et al. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 suppl 5 2010 v103 v115
5. E.E. Vokes, J.E. Herndon 2nd, and M.J. Kelley et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B J Clin Oncol 25 2007 1698 1704
6. N. Hanna, M. Neubauer, and C. Yiannoutsos et al. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology J Clin Oncol 26 2008 5755 5760
7. K. Kelly, K. Chansky, and L.E. Gaspar et al. Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023 J Clin Oncol 26 2008 2450 2456
8. Y. Segawa, K. Kiura, and N. Takigawa et al. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007 J Clin Oncol 28 2010 3299 3306
9. M.P. Edelstein, L.A. Wolf III, and D.S. Duch Potentiation of radiation therapy by vinorelbine (Navelbine) in non small cell lung cancer Semin Oncol 23 suppl 5 1996 41 47
10. E.E. Vokes, J.E. Herndon II, and J. Crawford et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIb non-small cell lung cancer: Cancer and Leukemia Group B study 9431 J Clin Oncol 20 2002 4191 4198
11. P. Fournel, G. Robinet, and P. Thomas et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne D'oncologie Thoracique-Groupe Français De Pneumo-Cancérologie NPC 95-01 study J Clin Oncol 23 2005 5910 5917
12. P. Zatloukal, L. Petruzelka, and M. Zemanova et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study Lung Cancer 46 2004 87 98
13. J. Jassem, R. Ramlau, and H. Karnicka-Mlodkowska et al. A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small cell lung cancer patients Ann Oncol 12 2001 1375 1381
14. E.H. Tan, J. Rolski, and T. Grodzki et al. Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and I.V. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer Ann Oncol 20 2009 1249 1256
15. M. Marty, P. Fumoleau, and A. Adenis et al. Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors Ann Oncol 12 2001 1643 1649
16. H. Bourgeois, J. Vermorken, and G. Dark et al. Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposure in patients with solid tumours Cancer Chemother Pharmacol 60 2007 407 413
17. M. Krzakowski, M. Provencio, and B. Utracka-Hutka et al. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial J Thorac Oncol 3 2008 994 1002
18. International Conference on Harmonisation (ICH) Guideline for Good Clinical Practice. ICH Harmonised Tripartite Guideline. E6(R1) ICH. April 1996.
19. Cancer Therapy Evaluation Program 1. Revised March 23, 1998. Common Toxicity Criteria, Version 2.0, March 1998.
20. P.A. Pizzo Management of fever in patients with cancer and treatment-induced neutropenia N Engl J Med 328 1993 1323 1332
21. A.B. Miller, B. Hoogstraten, and M. Staquet et al. Reporting results of cancer treatment Cancer 47 1981 207 214
22. J.O. Park, S.I. Lee, and S.Y. Song et al. Measuring response in solid tumors: comparison of RECIST and WHO response criteria Jpn J Clin Oncol 33 2003 533 537
23. G.A. Masters, D.J. Haraf, and P.C. Hoffman et al. Phase I study of vinorelbine, cisplatin and concomitant thoracic radiation in the treatment of advanced chest malignancies J Clin Oncol 16 1998 2157 2163
24. T. Hirose, Y. Mizutani, and T. Ohmori et al. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer Cancer Chemother Pharmacol 58 2006 361 367
25. C. Gridelli, C. Guida, and E. Barletta et al. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study Lung Cancer 29 2000 131 137